AQP10 and ovarian carcinoma: In the present study, we found that high expression of AQP10 mRNA predicted a better prognosis in all ovarian cancer patients mostly with serous subtypes, well-differentiated pathological grade (grade I) and advanced stage (III + IV) ovarian cancer.